Destruction of Pharmaceuticals

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

OFFICE ACQUISITION MANAGEMENT

Contract Value

Not provided

Codes & Classification
Solicitation Number

D-27-SL-0010

NAICS

-

Classification Code

-

Additional Details
Set Aside

None

Place of Performance

Saint Louis, Missouri, UNITED STATES

SourceSAM
Documents3
The Drug Enforcement Administration (DEA), operating under the Department of Justice, has issued a Special Notice regarding the destruction of pharmaceuticals in Saint Louis, Missouri. This procurement activity, identified by D-27-SL-0010, is managed by the Office Acquisition Management, a federal office responsible for overseeing acquisition processes within the agency. The primary objective of this notice is to secure services for the safe and compliant destruction of pharmaceuticals. The scope of work is centered on the proper disposal of controlled substances and other pharmaceutical materials, ensuring adherence to all applicable federal regulations and DEA guidelines. The intended outcome is to mitigate risks associated with the storage and handling of these substances, prevent diversion, and support the agency’s mission to enforce drug laws and regulations. Key requirements for prospective contractors include demonstrated expertise in pharmaceutical destruction, familiarity with regulatory compliance, and the ability to operate within the Saint Louis, Missouri area. Contractors must be capable of providing secure, environmentally responsible destruction services, with processes that meet DEA standards. Expected deliverables likely encompass the collection, transport, and destruction of pharmaceuticals, as well as documentation and certification of destruction activities. The contracting entity for this opportunity is the Office Acquisition Management within the DEA. The place of performance is specified as Saint Louis, Missouri, United States. Interested parties should direct inquiries to the primary contact, Jose Marin, via email at [email protected]. This notice is classified as a Special Notice and is currently active, with a response deadline of September 14, 2026. Contractors are encouraged to review the attached documents for further details and requirements. The opportunity is listed on SAM.gov under Opportunity ID f26f4562bdd741119f73a21b6c4ce6da. Contractors evaluating this opportunity should ensure their capabilities align with the DEA’s stringent requirements for pharmaceutical destruction, regulatory compliance, and secure operations. The core elements of this contract—safe destruction, regulatory adherence, and service delivery in Saint Louis—will remain constant throughout the contract lifecycle.